Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and monitor their blood glucose (blood sugar) readings in real time. Dexcom's ...

Medtech group Abbott has opened a new diabetes technology manufacturing plant in Kilkenny as part of a €440 million investment the company is making in two of its Irish facilities. More than 800 ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...

Increase in standard sensor life of Libre 2+ from 14 to 15 days is not recognised by xDrip+. Sensor runs for 15.5 days but end of life prediction is incorrect. xDrip+ was adamant my Libre 2+ sensor ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...

Freestyle Libre, a revolutionary flash glucose monitoring system, enables millions of people worldwide to monitor their blood sugar levels with ease. One of its biggest advantages is the ability to ...

The annual J.P. Morgan Healthcare Conference is an event where companies need to embrace the "go big or go home" mentality, and Abbott CEO Robert Ford certainly went big. Speaking about the company's ...

SAN DIEGO, June 20, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with ...

A clear and concise description of what the bug is. Describe what you see versus what you expect to see. When attempting to connect a new Libre 2+ sensor, I received ...

ABBOTT PARK, Ill. & SAN DIEGO--(BUSINESS WIRE)--Abbott (NYSE: ABT), the global health care company, and Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology ...